Sarepta Therapeutics, Inc. (BMV:SRPT)
Mexico · Delayed Price · Currency is MXN 411.00
-19.00 (-4.42%)
At close: Oct 10, 2025
Sarepta Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Cash & Equivalents | 510.6 | 1,103 | 428.43 | 966.78 | 2,116 | 1,503 | Upgrade |
Short-Term Investments | 289.54 | 251.78 | 1,248 | 1,023 | - | 435.92 | Upgrade |
Cash & Short-Term Investments | 800.14 | 1,355 | 1,676 | 1,989 | 2,116 | 1,939 | Upgrade |
Cash Growth | -45.21% | -19.18% | -15.74% | -5.98% | 9.15% | 72.36% | Upgrade |
Accounts Receivable | 527.3 | 601.99 | 400.33 | 214.63 | 152.99 | 101.34 | Upgrade |
Inventory | 994.04 | 749.96 | 322.86 | 203.97 | 186.21 | 231.96 | Upgrade |
Other Current Assets | 335.52 | 366.72 | 179.9 | 149.89 | 149.03 | 213.32 | Upgrade |
Total Current Assets | 2,657 | 3,073 | 2,579 | 2,558 | 2,604 | 2,485 | Upgrade |
Net Property, Plant & Equipment | 514.9 | 488.65 | 357.11 | 244.99 | 236.69 | 282.19 | Upgrade |
Other Intangible Assets | - | - | - | - | 14.24 | 13.63 | Upgrade |
Long-Term Investments | 230.13 | 136.87 | - | - | - | - | Upgrade |
Other Long-Term Assets | 277.81 | 264.19 | 328.14 | 325.51 | 292.95 | 203.7 | Upgrade |
Total Assets | 3,680 | 3,963 | 3,265 | 3,128 | 3,148 | 2,985 | Upgrade |
Accounts Payable | 136.7 | 214.44 | 164.92 | 95.88 | 76.74 | 111.09 | Upgrade |
Accrued Expenses | 377.4 | 373.51 | 315 | 419 | 271.7 | 193.55 | Upgrade |
Current Portion of Long-Term Debt | - | - | 105.48 | - | - | - | Upgrade |
Current Portion of Leases | - | - | - | 15.49 | - | - | Upgrade |
Unearned Revenue | 395.43 | 130.26 | 50.42 | 89.24 | 89.24 | 89.24 | Upgrade |
Other Current Liabilities | 10.42 | 13.47 | 17.85 | - | 15.05 | 22.14 | Upgrade |
Total Current Liabilities | 919.95 | 731.68 | 653.66 | 619.6 | 452.73 | 416.03 | Upgrade |
Long-Term Debt | 1,139 | 1,137 | 1,133 | 1,544 | 1,097 | 992.49 | Upgrade |
Long-Term Leases | 214.42 | 192.47 | 140.97 | 57.58 | 41.51 | 80.37 | Upgrade |
Other Long-Term Liabilities | 48.6 | 374.15 | 478.1 | 521.94 | 628.84 | 734.07 | Upgrade |
Total Long-Term Liabilities | 1,402 | 1,704 | 1,752 | 2,124 | 1,767 | 1,807 | Upgrade |
Total Liabilities | 2,322 | 2,435 | 2,405 | 2,743 | 2,220 | 2,223 | Upgrade |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade |
Treasury Stock | -25.26 | - | - | - | - | - | Upgrade |
Additional Paid-in Capital | 5,844 | 5,739 | 5,305 | 4,297 | 4,135 | 3,610 | Upgrade |
Accumulated Other Comprehensive Income | -0.05 | -0.22 | 0.92 | -1.66 | -0.02 | 0 | Upgrade |
Retained Earnings | -4,462 | -4,211 | -4,446 | -3,910 | -3,207 | -2,848 | Upgrade |
Shareholders' Equity | 1,357 | 1,528 | 859.34 | 384.95 | 928.01 | 761.76 | Upgrade |
Total Liabilities & Equity | 3,680 | 3,963 | 3,265 | 3,128 | 3,148 | 2,985 | Upgrade |
Total Debt | 1,354 | 1,330 | 1,379 | 1,617 | 1,138 | 1,073 | Upgrade |
Net Cash (Debt) | -553.74 | 25.2 | 297.29 | 372.02 | 977.48 | 865.71 | Upgrade |
Net Cash Growth | - | -91.53% | -20.09% | -61.94% | 12.91% | 119.10% | Upgrade |
Net Cash Per Share | -5.07 | 0.23 | 3.22 | 4.25 | 12.03 | 11.11 | Upgrade |
Book Value | 1,357 | 1,528 | 859.34 | 384.95 | 928.01 | 761.76 | Upgrade |
Book Value Per Share | 12.42 | 14.16 | 9.30 | 4.40 | 11.42 | 9.77 | Upgrade |
Tangible Book Value | 1,357 | 1,528 | 859.34 | 384.95 | 913.77 | 748.13 | Upgrade |
Tangible Book Value Per Share | 12.42 | 14.16 | 9.30 | 4.40 | 11.24 | 9.60 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.